Stocks and Investing Stocks and Investing
Fri, March 1, 2024

Silvan Tuerkcan Initiated (ACRV) at Buy and Held Target at $14 on, Mar 1st, 2024


Published on 2024-10-28 09:22:26 - WOPRAI, Silvan Tuerkcan
  Print publication without navigation


Silvan Tuerkcan of JMP Securities, Initiated "Acrivon Therapeutics, Inc." (ACRV) at Buy and Held Target at $14 on, Mar 1st, 2024.

Silvan has made no other calls on ACRV in the last 4 months.



There is 1 other peer that has a rating on ACRV. Out of the 1 peers that are also analyzing ACRV, 0 agree with Silvan's Rating of Hold.



This is the rating of the analyst that currently disagrees with Silvan


  • Etzer Darout of "BMO Capital" Maintained at Buy with Decreased Target to $24 on, Friday, November 10th, 2023

Contributing Sources